98%
921
2 minutes
20
Background: Although the optimization of brain oxygenation is thought to improve the prognosis, the effect of brain tissue oxygen pressure (PbtO2) for patients with severe traumatic brain injury (STBI) remains controversial. Therefore, the present study aimed to determine whether adding PbtO2 to intracranial pressure (ICP) monitoring improves clinical outcomes for patients with STBI.
Methods: PubMed, Embase, Scopus and Cochrane Library were searched for eligible trials from their respective inception through April 10th, 2024. We included clinical trials contrasting the combined monitoring of PbtO and ICP versus isolated ICP monitoring among patients with STBI. The primary outcome was favorable neurological outcome at 6 months, and secondary outcomes including the in-hospital mortality, long-term mortality, length of stay in intensive care unit (ICU) and hospital.
Results: A total of 16 studies (four randomized studies and 12 cohort studies) were included in the meta-analysis. Compared with isolated ICP monitoring, the combined monitoring was associated with a higher favorable neurological outcome rate at 6 months (RR 1.33, 95% CI [1.17-1.51], < 0.0001, I = 0%), reduced long-term mortality (RR 0.72, 95% CI [0.59-0.87], = 0.0008, I = 2%). No significant difference was identified in the in-hospital mortality (RR 0.81, 95% CI 0.66 to 1.01, = 0.06, I = 32%), length of stay in ICU (MD 2.10, 95% CI [-0.37-4.56], = 0.10, I = 78%) and hospital (MD 1.07, 95% CI [-2.54-4.67], = 0.56, I = 49%) between two groups. However, the pooled results of randomized studies did not show beneficial effect of combined monitoring in favorable neurological outcome and long-term mortality.
Conclusions: Currently, there is limited evidence to prove that the combined PbtO2 and ICP monitoring may contribute to improved neurological outcome and long-term mortality for patients with STBI. However, the benefit of combined monitoring should be further validated in more randomized studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11468803 | PMC |
http://dx.doi.org/10.7717/peerj.18086 | DOI Listing |
Biosens Bioelectron
September 2025
Cancer Research Institute, The First Affiliated Hospital, University of South China, Hengyang, 421001, PR China; State Key Laboratory of Chemo/Biosensing and Chemometrics, School of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR China. Electronic address:
A highly sensitive, selective, and simple method for detecting uranyl ions (UO) is crucial for human health and environmental safety. Amidoxime-based nanomaterials have been widely employed for UO detection, but their higher affinity for vanadium than UO limits their practical applications. Herein, a novel covalent organic polymer fluorescent probe (TT-COP) for UO detection was innovatively developed by a one-step Schiff-base condensation reaction between 3,3',5,5'-tetramethylbenzidine (TMB) and 2,4,6-triformylphloroglucinol (Tp).
View Article and Find Full Text PDFAnal Chem
September 2025
Chemical Sciences Division, Material Measurement Laboratory, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, Maryland 20899-1070, United States.
In response to the growing concern of microplastics (1 μm to 5 mm) accumulation affecting human health, the development of analytical methods continues to be critical for the detection and characterization of microplastic particles. In this context, pursuing exceptional particle detection capability down to practical low levels and rapid analyses with high sample throughput makes single particle inductively coupled plasma mass spectrometry (spICP-MS) very attractive for microplastics analysis. Existing spICP-MS-based studies have routinely shown limitations in the accurate sizing and quantification of particle number concentration through targeting carbon content, with reported size limits of detection in the range of 0.
View Article and Find Full Text PDFBiomater Investig Dent
August 2025
Department of Biomaterials and Oral Biology, School of Dentistry, University of São Paulo, São Paulo, Brazil.
Introduction: Ca release from specimens made of a composite containing dicalcium phosphate dihydrate particles (CaHPO.2HO, dicalcium phosphate dihydrate [DCPD]) was followed during 1 year.
Methods: Specimens were individually immersed in deionized water ( = 3).
Background: Decompressive hemicraniectomy (DHC) can improve outcome in patients with elevated intracranial pressure (ICP) refractory to medical therapy. However, this transition point for treating refractory ICPs with DHC is unclear as ICPs can often be controlled with escalating doses of medical management. A more individualized and precise way to monitor and define medically "refractory ICP" may be achieved with the utilization of a quantitative electroencephalography (EEG) parameter called burst suppression ratio (BSR).
View Article and Find Full Text PDFEur J Pediatr
September 2025
Department of Surgical Intensive Care Unit, Children's Hospital of Nanjing Medical University, No.72 Guangzhou Road, Nanjing, 210008, Jiangsu Province, China.
Unlabelled: Monitoring the dynamic changes in intracranial pressure (ICP) is crucial for assessing clinical outcomes in pediatric intracranial hemorrhage (ICH). However, the ICP trajectory patterns remain unknown. We aim to identify distinct ICP trajectory patterns in pediatric ICH and assess their impact on clinical outcomes.
View Article and Find Full Text PDF